Properties (50)
Predicate | Object |
---|---|
gptkbp:instanceOf |
chemical compound
|
gptkbp:availability |
online vendors
|
gptkbp:chemicalFormula |
C15H21N
arylcyclohexylamine |
gptkbp:communityInvolvement |
controversial
polarizing |
gptkbp:composedOf |
requires specific precursors
|
gptkbp:culturalHeritage |
featured in documentaries
analyzed in academic papers discussed in podcasts included in harm reduction literature mentioned in online forums |
gptkbp:drugInterdiction |
moderate
|
gptkbp:duration |
3 to 6 hours
|
gptkbp:festivals |
limited
|
https://www.w3.org/2000/01/rdf-schema#label |
MXE
|
gptkbp:impact |
anxiety
dizziness introspection nausea relaxation euphoria dissociation hallucinations increased heart rate altered perception dissociative |
gptkbp:is_available_in |
2010
limited |
gptkbp:isATypeOf |
123456-78-9
|
gptkbp:legal_representation |
varies by country
|
gptkbp:marketedAs |
research chemical
|
gptkbp:notable_event |
adverse reactions
overdose cases |
gptkbp:notableUsers |
researchers
psychoactive substance enthusiasts |
gptkbp:nutritionalValue |
primarily by liver enzymes
|
gptkbp:origin |
(S)-2-(3-methoxyphenyl)-2-(ethylamino)cyclohexan-1-ol
|
gptkbp:related_to |
ketamine
DXM PCP methoxetamine |
gptkbp:religion |
can develop with repeated use
|
gptkbp:reportsTo |
variable experiences
|
gptkbp:research |
limited studies
|
gptkbp:research_focus |
therapeutic potential
psychedelic properties |
gptkbp:route |
oral
|
gptkbp:safety_features |
not fully established
|
gptkbp:symptoms |
not well documented
|